CHEK2 and breast cancer: A study by Schreurs et al. analysed the changes in surveillance category by adding a polygenic risk score based on 311 breast cancer-associated variants (PRS311), questionnaire-based risk factors, and breast density on personalised breast cancer risk in unaffected women from Dutch CHEK2 c.1100delC families [67].